Narbada Hospital And Medical Research Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 7.51 Cr
as on 18-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Narbada Hospital And Medical Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Devendra Jain, Dharmendra Chundawat, and Nathu Dangi serve as directors at the Company.
- CIN/LLPIN
U93090GJ2017PLC097531
- Company No.
097531
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Narbada Hospital And Medical Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devendra Jain  | Director | 07-Mar-2022 | Current |
| Dharmendra Chundawat | Director | 06-Jul-2020 | Current |
| Nathu Dangi | Director | 19-Apr-2022 | Current |
Financial Performance of Narbada Hospital And Medical Research.
Narbada Hospital And Medical Research Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Narbada Hospital And Medical Research?
In 2018, Narbada Hospital And Medical Research had a promoter holding of 98.54% and a public holding of 1.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dhawal Marbles And Granites LimitedActive 29 years 1 monthDevendra Jain, Dharmendra Chundawat and 1 more are mutual person
- Garden Real Estates And Hotels LimitedActive 32 years 5 months
Devendra Jain, Dharmendra Chundawat and 1 more are mutual person
- Euro Asia Marble Trading Company Private LimitedActive 27 years 5 months
Devendra Jain and Dharmendra Chundawat are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Narbada Hospital And Medical Research?
Unlock and access historical data on people associated with Narbada Hospital And Medical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narbada Hospital And Medical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narbada Hospital And Medical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
